Related Experiment Video
Updated: May 21, 2026

08:02
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Topical and systemic therapies for nickel allergy
Antonella Tammaro1, Alessandra Narcisi, Severino Persechino
1Department of Dermatology, University of Rome Sapienza, Rome, Italy.
Dermatitis : Contact, Atopic, Occupational, Drug
|June 2, 2012
Summary
Nickel allergy causes skin and systemic issues, including a severe form called Systemic nickel allergy syndrome. This review covers past and current therapies for nickel contact allergy.
Area of Science:
- Allergy and Immunology
- Dermatology
- Gastroenterology
Background:
- Nickel allergy presents with diverse cutaneous and systemic symptoms, varying in severity.
- Systemic nickel allergy syndrome (SNAS) is a severe manifestation involving chronic dermatitis and systemic effects like gastrointestinal issues.
- SNAS symptoms can mimic celiac disease due to gastrointestinal mucosal alterations.
Purpose of the Study:
- To provide a concise update on existing and emerging therapies for nickel contact allergy.
- To summarize current knowledge on managing Systemic nickel allergy syndrome.
- To review treatment strategies for both cutaneous and systemic manifestations of nickel allergy.
Main Methods:
- Literature review of past and current therapeutic approaches for nickel allergy.
- Analysis of clinical characteristics and diagnostic criteria for Systemic nickel allergy syndrome.
- Synthesis of information on treatments targeting both skin and systemic symptoms.
Main Results:
- Nickel allergy encompasses a spectrum of reactions from mild to severe.
- Systemic nickel allergy syndrome presents with significant dermatological and gastrointestinal symptoms.
- Therapeutic options for nickel allergy are evolving.
Conclusions:
- Effective management of nickel allergy requires addressing both cutaneous and systemic symptoms.
- Further research into novel therapies for Systemic nickel allergy syndrome is warranted.
- Understanding the link between nickel allergy and gastrointestinal health is crucial for comprehensive patient care.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

